192 IgG-saporin lesion of basal forebrain cholinergic neurons in neonatal rats

Developmental Brain Research

Volumn 96, Issue 1-2, 1996, Pages 52-61

  Pappas, B A ^a   Davidson, C M ^a   Fortin, T ^a   Nallathamby, S ^a   Park, G A S ^a   Mohr, E ^b   Wiley, R G ^c  

^a CARLETON UNIVERSITY   (Canada)

^b Élisabeth Bruyére Health Centre   (Canada)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

192 IgG saporin; acetylcholine; brain development; Down syndrome; hippocampus; Rett syndrome; spatial learning memory; sympathetic ingrowth

Indexed keywords

CHOLINE ACETYLTRANSFERASE; NEUROTOXIN; NEUROTROPHIN RECEPTOR; SAPORIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BEHAVIOR; BRAIN DEVELOPMENT; BRAIN INJURY; CHOLINERGIC SYSTEM; CONTROLLED STUDY; DOWN SYNDROME; HIPPOCAMPUS; IMMUNOHISTOCHEMISTRY; LEARNING; MALE; MEMORY; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALIA;

EID: 0030599371     PISSN: 01653806     EISSN: None     Source Type: Journal    
DOI: 10.1016/0165-3806(96)00095-8     Document Type: Article

References (38)

1. [1] Angeletti, P.U. and Levi-Montalcini, R., Growth regulation of the sympathetic nervous system: immunosympathectomy and chemical sympathectomy, Rev. Eur. Etudes Clin. Biol., 16 (1971) 866-874.
2. [2] Armstrong, J.N. and Pappas, B.A., The histopathological, behavioral and neurochemical effects of intraventricular injection of ethylcholine mustard aziridinium (AF64A) in the neonatal rat, Dev. Brain Res., 61 (1991) 249-257.
3. [3] Bachman, E.S., Berger-Sweeney, J., Coyle, J.T. and Hohmann, C.F., Developmental regulation of adult cortical morphology and behavior - an animal model for mental retardation. Int. J. Dev. Neurosci., 12 (1994) 239-253.
4. [4] Berger-Sweeney, J., Heckers, S., Mesulam, M.-M., Wiley, R.G., Lappi, D.A. and Sharma, M., Differential effects on spatial navigation of immunotoxin-induced cholinergic lesions of the medial septal area and nucleus basalts magnocellularis, J. Neurosci., 14 (1994) 4507-4519.
5. [5] Book, A.A., Wiley, R.G. and Schweitzer, J.B., 192 IgG-saporin: I. Specific lethality for cholinergic neurons in the basal forebrain of the rat, J. Neuropathol. Exp. Neurol., 53 (1994) 95-102.
6. [6] Brake, W.G. and Pappas, B.A., Hemicholinium-3 (HC3) blocks the effects of ethylcholine mustard aziridinium (AF64A) in the developing rat, Dev. Brain Res., 83 (1994) 289-293.
7. [7] Claytor, K.J., Leslie, F.M., Wiley, R.G., Yu, J. and Robertson, R.T., Development of cholinergic receptors in forebrains of rats with 192 IgG-saporin induced cholinergic deficits, Neurosci. Abstr., 21 (1995) 1782.
8. [8] Chen, C.-K., Kinsman, S.L., Holtzman, D.M., Mobley, W.C. and Johnston, M.V., A reverse transcription-polymerase chain reaction study of p75 nerve growth factor receptor gene expression in developing rat cerebellum, Int. J. Dev. Neurosci., 12 (1994) 255-262.
9. [9] Coyle, J.T., Price, D.L. and DeLong, M.R., Alzheimer's disease: a disorder of cortical cholinergic innervation, Science, 219 (1983) 1184-1190.
10. [10] Coyle, J.T., Oster-Granite, M.L. and Gearhart, J.D., The neurobiologic consequences of Down syndrome, Brain Res. Bull., 16 (1986) 773-787.
11. [11] Crutcher, K.A., Sympathetic sprouting in the central nervous system: a model for studies of axonal growth in the mature mammalian brain, Behav. Brain Res., 12 (1987) 203-233.
12. [12] Crutcher, K.A., Neonatal septal lesions result in sympathohippocampal innervation in the adult rat, Exp. Neurol., 76 (1982) 1-11.
13. [13] de la Torre, J.C., Fortin, T., Park, G.A.S., Pappas, B.A. and Richard, M., Brain Blood flow restoration "rescues" chronically damaged rat CA1 neurons, Brain Res., 623 (1993) 6-15.
14. [14] Florez, J., del Arco, C., Gonzalez, A., Pascual, J. and Pazos, A., Autoradiographic studies of neurotransmitter receptors in the brain of newborn infants with Down syndrome, Am. J. Med. Gen., 7 Suppl. (1990) 301-305.
15. [15] Fonnum, F., A rapid radiochemical method for the determination of choline acetyltransferase, J. Neurochem., 24 (1975) 407-409.
16. 3H]hemicholinium-3, J. Comp. Neurol., 321 (1992) 591-611.
17. [17] Harrell, L.E. and Parsons, D.S., The role of cortical sympathetic ingrowth in the behavioral effects of nucleus basalis magnocellularis lesions, Brain Res., 474 (1988) 353-358.
18. [18] Heckers, S., Ohtake, T., Wiley, R.G., Lappi, D.A., Geula, C. and Mesulam, M.M., Complete and selective cholinergic denervation of rat neocortex and hippocampus but not amygdala by an immunotoxin against the p75 NGF receptor, J. Neurosci., 14 (1994) 1271-1289.
19. [19] Hobmann, C.F., Brooks, A.R. and Coyle, J.T., Neonatal lesions of the basal forebrain cholinergic neurons result in abnormal cortical development, Dev. Brain Res., 42 (1988) 253-264.
20. [20] Hohmann, C.F., Kwiterovich, C., Oster-Granite, M.L. and Coyle, J.T., Newborn basal forebrain lesions disrupt cortical cytodifferentiation as visualized by rapid Golgi staining, Cereb. Cortex, 1 (1991) 143-172.
21. [21] Kawaja, M.D., Distribution of sympathetic axons in the brains of transgenic mice overexpressing nerve growth factor, Neurosci. Abstr., 19 (1993) 35.
22. [22] Kish, S., Karlinsky, H., Becker, L., Gilbert, J., Rebbetoy, M., Chang, L.-J., DiStefano, L. and Hornykiewicz, O., Down's syndrome individuals begin life with normal levels of brain cholinergic mark markers, J. Neurochem., 52 (1989) 1183-1187.
23. [23] Koh, S. and Loy, R., Localization and development of nerve growth factor-sensitive rat basal forebrain neurons and their afferent projections to hippocampus and cortex, J. Neurosci., 9 (1989) 2999-3018.
24. [24] Leanza, G., Nilsson, O.G., Wiley, R.G. and Bjorklund, A., Dose-related effects of 192 IgG-saporin on basal forebrain cholinergic neurons: biochemical, immunocytochemical and behavioral studies on neonatal and adult rats, Neurosci. Abstr., 19 (1993) 1890.
25. [25] McDonald, J.W. and Johnston, M.V., Physiological and pathophysiological roles of excitatory amino acids during central nervous system development, Brain Res. Rev., 15 (1990) 41-70.
26. [26] Murtha, S.J.E. and Pappas, B.A., Neurochemical, histopathological and mnemonic effects of combined lesions of the medial septal and serotonin afferents to the hippocampus, Brain Res., 651 (1994) 16-26.
27. [27] Pappas, B.A., Murtha, S.J.E., Park, G.A.S., Condon, K.T., Szirtes, R.M., Laventure, S.I. and Ally, A., Neonatal brain dopamine depletion and the cortical and behavioral consequences of enriched post-weaning environment, Pharmacol. Biochem. Behav., 42 (1992) 741-748.
28. [28] Paxinos, G. and Watson, C., The Rat Brain in Stereotaxic Coordinates, 2nd edn., Academic Press, New York, 1986.
29. [29] Robertson, R.T., Gallardo, K.A., Wiley, R.G. and Yu, J., Growing up without a basal forebrain: neonatal treatment with 192 IgG-saporin results in long term cerebral cortical cholinergic deficits, Neurosci. Abstr., 19 (1993) 50.
30. [30] Robertson, R.T., Yu, B.P., Kageyama, G.H., Claytor, K.J., Lauterborn, J.C., Gall, C.M. and Wiley, R.G., Neonatal treatment with 192 IgG-saporin produces deficits in forebrain cholinergic systems, Neurosci. Abstr., (1994) 1320.
31. [31] Sengstock, G.J., Johnson, K.B., Jantzen, P.T., Meyer, E.M., Dunn, A.J. and Arendash, G.W., Nucleus basalis lesions in neonate rats induce a selective cortical cholinergic hypofunction and cognitive deficits during adulthood, Exp. Brain Res., 90 (1992) 163-174.
32. [32] Singh, B. and de Champlain, J., Ontogenesis of sympathetic fibres after neonatal 6-hydroxydopamine treatment in the rat, Can. J. Physiol. Pharmacol., 52 (1974) 304-318.
33. [33] Waite, J.J., Chen, A.D., Wardlow, M.L., Wiley, R.G., Lappi, D.A. and Thal, L.J., 192 Immunoglobulin G-saporin produces graded behavioral and biochemical changes accompanying the loss of cholinergic neurons of the basal forebrain and cerebellar Purkinje cells, Neuroscience, 65 (1995) 463-476.
34. [34] Wenk, G.L., Stoehr, J.D., Quintana, G., Mobley, S. and Wiley, R.G., Behavioral, biochemical, histological, and electrophysiological effects of 192 IgG-saporin injections into the basal forebrain of rats, J. Neurosci., 14 (1990) 5986-5995.
35. [35] Wenk, G.L., Naidu, S., Casanova, M.F., Kitt, C.A. and Moser, H., Altered neurochemical markers in Rett's syndrome, Neurology, 41 (1991) 1753-1756
36. [36] Wenk, G.L., O'Leary, M., Nemeroff, C.B., Bissette, G., Moser, H. and Naidu, S., Neurochemical alterations in Rett syndrome, Dev. Brain Res., 74 (1993) 67-72.
37. [37] Whittemore, S.R., Larkfors, L., Ebendal, T., Holets, V.R., Ericsson, A. and Person, H., Increased β-nerve growth factor messenger RNA and protein levels in neonatal rat hippocampus following specific cholinergic lesions, J. Neurosci., 7 (1987) 244-251.
38. [38] Wiley, R.G., Oeltmann, T.N. and Lappi, D.A., Immunolesioning: selective destruction of neurons using immunotoxin to rat NGF receptor, Brain Res., 562 (1991) 149-153.